Wonderland 2023 Review: PsychMD

Microdose
Tue, Nov 21
Key Points
  • PsychMD was the Headline Sponsor for the Wonderland 2023 event, which focuses on psychedelic medicine, longevity, and mental health.
  • The company launched an affordable telehealth model aimed at increasing patient access to important therapies, particularly ketamine treatments.
  • PsychMD was involved in panels and discussions at the event, sharing their expertise and personal motivations for getting involved in psychedelic medicine.
  • PsychMD's advisor and consultant on veteran issues, Giorgios Kirylos, shared his inspiring story of healing and veteran advocacy at the event.

With Wonderland 2023 still fresh in our rear-view mirrors, let’s take a moment to look at some of the highlights from the big event. The Wonderland conference has evolved, expanding from a leading psychedelic medicine event to include related wellness sectors like longevity and mental health. 

Taking this next step to lead the way into the future of wellness is a massive undertaking — one that wouldn’t be possible without the support of our speakers, exhibitors, attendees, and sponsors. They are crucial to both the Wonderland event and the future of the psychedelic medicine industry.

So we’ll start our review by looking at PsychMD, the Headline Sponsor for Wonderland 2023.

 

The past year has seen a string of ketamine clinic closures across the psychedelic medicine space, leaving patients suddenly without treatment options. We heard from military veterans scrambling to find alternatives, desperate to continue ketamine treatments that were literally saving their lives. 

Enter PsychMD and the launch of an affordable telehealth model aimed at increasing patient access to important therapies. 

The company was already the largest telemedicine provider for men and women in the wellness area (PeterMD and PetraMD), giving them a solid foundation to push off into the ketamine space and treat patients nationally. 

 

“I’m a patient myself. I’ve seen the resilts. So it’s very personal for me. We believe people should be able to afford the treatments they need.”

– PsychMD President Bryan Henry.

 

The PsychMD team was a big part of the Wonderland experience, telling not only the company story, but the personal motivations for getting involved in psychedelic medicine. PsychMD founder and president Byran Henry was part of the following insightful panels:

This insightful discussion featured mental health professionals and individuals with lived experiences with ketamine’s power to inspire recovery and resilience. By sharing knowledge and stories, the panel showed how ketamine therapy can deeply transform the lives of those who have sacrificed so much to serve our communities. 

A discussion and objective overview of the possible benefits and risks of maintaining optimal hormone levels into older age.

 

PsychMD’s advisor and consultant on veteran issues, Giorgios Kirylos, was also involved, sharing his inspiring story of healing and veteran advocacy:

A discussion on the intersection of veterans’ experiences and the potential benefits of psychedelics for mental health and well-being, fostering a deeper understanding of the unique challenges faced by veterans.

In an eye-opening keynote, Giorgio Kirylo relates his deeply personal story of serving his country and then fighting for proper mental health care upon returning home. He transports listeners through his deployments, the trauma he endured, and the frustrating bureaucracy he faced trying to get PTSD treatment. Kirylo makes a compelling case for expanding innovative therapies like ketamine to help veterans dealing with depression, anxiety, and trauma. 

 

 

A post shared by Microdose Psychedelic Insights (@microdosehq)